CEO at Stealth BioTherapeutics.
Reenie McCarthy is the Chief Executive Officer and a member of the Board of Stealth BioTherapeutics, a biopharmaceutical company developing investigational therapies to treat mitochondrial dysfunction. Reenie is a 20+ year veteran of the investment team of Morningside, Stealth’s principal investor. Reenie has extensive experience working with numerous private nonclinical and clinical stage companies developing drugs across a broad spectrum of therapeutic areas and providing operational and management oversight to venture-backed technology companies. Reenie has been involved with Stealth since 2009, before stepping into a dedicated leadership role at the company in 2015.
Visit website: https://www.stealthbt.com/our-company/#leadership
See also: Stealth BioTherapeutics - Biopharmaceutical company focused on the discovery and commercialization of novel therapies..
Reenie McCarthy is also referenced in the following:
The virtual event for leaders in longevity science, technology, business and finance organized by Longevity Leaders (LSX).
Reenie McCarthy News
Super summary of 3rd Annual Longevity Therapeutics Summit
Lifespan.io (LEAF) - 16-Feb-2021
More and more companies making greater and greater progress - 2021 could be an exciting yearRead more...